It is most likely that the decrease observed in DSG1, DSC1 and JUP seen in the BPD group, which is reversed by combination inhaler therapy, is due to cellular injury secondary to continuing airway inflammation38,39, although further work is needed to clarify this speculation. The gene discussed is DSG1; the disease is bronchopulmonary dysplasia.